C21H17F3N4O4
Neat
446.39
Sorafenib Impurity 9; 862875-16-9; 4-(4-(3-(4-Hydroxy-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide; 4-[4-[[4-hydroxy-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide; Sorafenib Impurity 38; K4AX5J8PYE; SCHEMBL5568327; NUDOMXMCXPMNQE-UHFFFAOYSA-N; 2-Pyridinecarboxamide and 4-[4-[[[[4-hydroxy-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl; 4-[4-[[[[4-Hydroxy-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
4-[4-[[4-hydroxy-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
InChI=1S/C21H17F3N4O4/c1-25-19(30)17-11-15(8-9-26-17)32-14-5-2-12(3-6-14)27-20(31)28-13-4-7-18(29)16(10-13)21(22,23)24/h2-11,29H,1H3,(H,25,30)(H2,27,28,31)